Fibrillar collagens have a long triple helix in which glycine is in every t
hird position for more than 1000 amino acids. The three chains of these mol
ecules are assembled with specificity into several different molecules that
have tissue-specific distribution. Mutations that alter folding of either
the carboxy-terminal globular peptides that direct chain association, or of
the regions of the triple helix that are important for nucleation, or of t
he bulk of the triple helix, all result in identifiable genetic disorders i
n which the phenotype reflects the region of expression of the genes and th
eir tissue-specific distribution. Mutations that result in changed amino-ac
id sequences in any of these regions have different effects on folding and
may have different phenotypic outcomes. Substitution for glycine residues i
n the triple helical domains are among the most common effects of mutations
, and the nature of the substituting residue and its location in the chain
contribute to the effect on folding and also on the phenotype. More complex
mutations, such as deletions or insertions of triple helix, also affect fo
lding, probably because of alterations in helical pitch along the triple he
lix. These mutations all interfere with the ability of these molecules to f
orm the characteristic fibrillar array in the extracellular matrix and many
result in intracellular retention of abnormal molecules.